November 10, 2025
PreOmics Launches New Plasma Proteomics Solution P2-iST and Announces the Formation of Biognosys Group • P2-iST Plasma Launch: The new nanoparticle-based plasma proteomics workflow combines Biognosys’ P2 Plasma Enrichment with PreOmics’ iST technology, achieving identification of nearly 6,000 plasma proteins with >90% data completeness, exceptional precision, and scalability up to 192 samples processed per day. [...]
SMi Systems Appoints Ronnie Andrews of Bethesda Group Advisors as Non-Executive Director
November 10, 2025
LONDON -- SMi Systems, a leading innovator in single-molecule detection for drug discovery and diagnostics, announces the appointment of Ron Andrews, Founder and Managing Partner of Bethesda Group Advisors, to its Board of Directors as a Non-Executive Director. During more than 35 years of strategic leadership in the Life Sciences Tools and Molecular Diagnostics sectors, Mr Andrews [...]
Avantor® Appoints Mary Blenn as Executive Vice President and Chief Operating Officer
November 10, 2025
RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced that Mary Blenn has been appointed to the newly created role of Executive Vice President and Chief Operating Officer, effective immediately. Ms. Blenn will report to President and CEO [...]
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
November 10, 2025
Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end [...]
November 10, 2025
WALTHAM, Mass. -- Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the National Institute of Standards and Technology (NIST) as part of the Somatic Reference Samples (SRS) Initiative. The Somatic Reference Samples (SRS) Initiative is a public-private partnership convened and [...]
November 10, 2025
TeraView is pleased to announce a newly granted US patent that covers a pioneering test system designed for devices with multiple electrical contacts, integrating a movable probe assembly and a sophisticated profile-determining system. This system ensures precise mapping and reliable testing of advanced 2.5/3D packaging used in chips for artificial intelligence (AI), machine learning as well [...]
Bruker Announces Advancements in Immunopeptidomics, de novo PTM Analysis, and Proteoform Profiling
November 10, 2025
A. ProteoScape™ (PS) software integrates the Kuiper machine learning-enhanced search engine, for immunopeptides, and TagGraph for neoepitope discovery. B. OmniScape™ + timsOmni™: next-generation de novo and glycoproteomics workflows with residue-aware scoring and intuitive visualization to accelerate intact proteoform and PTM analysis. C. Bruker and IPT announce a joint initiative to combine SampleStream™ with timsOmni™ for [...]
FOSS Group acquires Wasatch Photonics
November 10, 2025
FOSS announces the acquisition of North American spectrometer specialist Wasatch Photonics. Hillerød, Denmark – The Danish family-owned company continues its investments within photonics and optics, this time with one of the biggest acquisitions in the history of the family business, spending just under DKK 250 million for the full ownership of the company. Wasatch Photonics is [...]
ERS Genomics and Dyadic Applied BioSolutions Sign CRISPR/Cas9 License Agreement
November 10, 2025
License enables Dyadic Applied BioSolutions to expand genetic engineering capabilities Dublin, Ireland, and Jupiter FL, USA: ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions (‘Dyadic’), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for diverse commercial applications, today announced they have signed a non-exclusive agreement granting access to ERS’ foundational [...]
November 10, 2025
Hamburg Germany -- acCELLerate, a manufacturer of assay-ready frozen cells has established an agreement with ATCC a global biological resource and standards organization. Under the agreement, acCELLerate will produce custom cell banks from ATCC cell lines for research clients in the pharmaceutical and biotechnology industry. This collaboration combines ATCC’s internationally recognized portfolio of high-quality, authenticated [...]

